was read the article
array:22 [ "pii" => "S2173572720301594" "issn" => "21735727" "doi" => "10.1016/j.medine.2019.12.013" "estado" => "S300" "fechaPublicacion" => "2020-10-01" "aid" => "1451" "copyright" => "Elsevier España, S.L.U. and SEMICYUC" "copyrightAnyo" => "2020" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Intensiva. 2020;44:397-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S2173572720301582" "issn" => "21735727" "doi" => "10.1016/j.medine.2019.09.007" "estado" => "S300" "fechaPublicacion" => "2020-10-01" "aid" => "1406" "copyright" => "Elsevier España, S.L.U. and SEMICYUC" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Med Intensiva. 2020;44:399-408" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original</span>" "titulo" => "Changes of resistance rates in <span class="elsevierStyleItalic">Pseudomonas aeruginosa</span> strains are unrelated to antimicrobial consumption in ICU populations with invasive device-related infection" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "399" "paginaFinal" => "408" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Los cambios en la resistencia de cepas de <span class="elsevierStyleItalic">Pseudomonas aeruginosa</span> identificadas en infecciones relacionadas con dispositivos invasores no se relacionan con el consumo de antibióticos en la UCI" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1467 "Ancho" => 2338 "Tamanyo" => 240120 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Linear evolution of consumption of antipseudomonal antimicrobials (expressed as DOT) in Spanish ICUs participating in the ENVIN-HELICS registry. (AMK: amikacin; CFP: cefepime; CTZ: ceftazidime; LVX: levofloxacin; CPX: ciprofloxacin; IMP: imipenem; MRP: meropenem; PP_T: piperacillin-tazobactam; COL: colistin).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Álvarez-Lerma, P. Olaechea-Astigarraga, R. Gimeno, M. Catalan, X. Nuvials, M.P. Gracia-Arnilla, M. Palomar-Martínez, I. Seijas-Betolaza, M. Martínez-Alonso" "autores" => array:10 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Álvarez-Lerma" ] 1 => array:2 [ "nombre" => "P." "apellidos" => "Olaechea-Astigarraga" ] 2 => array:2 [ "nombre" => "R." "apellidos" => "Gimeno" ] 3 => array:2 [ "nombre" => "M." "apellidos" => "Catalan" ] 4 => array:2 [ "nombre" => "X." "apellidos" => "Nuvials" ] 5 => array:2 [ "nombre" => "M.P." "apellidos" => "Gracia-Arnilla" ] 6 => array:2 [ "nombre" => "M." "apellidos" => "Palomar-Martínez" ] 7 => array:2 [ "nombre" => "I." "apellidos" => "Seijas-Betolaza" ] 8 => array:2 [ "nombre" => "M." "apellidos" => "Martínez-Alonso" ] 9 => array:1 [ "colaborador" => "ENVIN-HELICS Study Group" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572720301582?idApp=WMIE" "url" => "/21735727/0000004400000007/v1_202010040640/S2173572720301582/v1_202010040640/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Bacterial resistance unrelated to antibiotic use: The perfect excuse?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "397" "paginaFinal" => "398" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "M. Sánchez-García" "autores" => array:1 [ 0 => array:3 [ "nombre" => "M." "apellidos" => "Sánchez-García" "email" => array:1 [ 0 => "miguelsanchez.hcsc@gmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Critical Care Department, Hospital Clínico San Carlos, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "La resistencia bacteriana no está relacionada con el consumo de antibióticos: ¿la excusa perfecta?" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Guidelines, recommendations and stewardship programmes<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">1–3</span></a> propose limiting antimicrobial exposure in humans as the core intervention to combat bacterial resistance. Specifically, it is expected that the risk of development of bacterial resistance to antibiotics will be reduced by shortening therapy and prophylaxis, as well as avoiding indications like colonization or non-bacterial infections. The underlying concept of these proposals is that direct contact of antimicrobials with the patient's flora provides a survival benefit to intrinsically resistant microorganisms by eliminating those that are susceptible and/or directly induces mechanisms of resistance. A multitude of more or less radical experiences limiting antimicrobial drug exposure<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">4</span></a> (see also references 1–11 and 25–34 in Álvarez-Lerma<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">5</span></a>) support that this strategy is associated with reduction, whereas increases are followed by worsening rates of resistance.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">6</span></a> In discrepancy with these experiences and the accepted dogma, however, Álvarez-Lerma et al. report in this issue of <span class="elsevierStyleItalic">Medicina Intensiva</span> that consumption of several antipseudomonal antibiotics and their respective resistance in <span class="elsevierStyleItalic">Pseudomonas aeruginosa</span> are statistically unrelated.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">5</span></a> The authors review ten years of the 3-monthly, April to June, Spanish National Nosocomial ICU-acquired Infection Surveillance Study (ENVIN-HELICS).<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">7</span></a> A data base of 187.100 critically ill patients, 11.652 (6.2%) of whom developed device-associated infection, 2.095 (13.6%) caused by <span class="elsevierStyleItalic">P. aeruginosa</span>, provides susceptibility data and consumption in days of antipseudomonal drug treatment over the 10-year study period. The author's analyses show that significant reductions in consumption of aminoglycosides, ceftazidime, cefepime, quinolones and carbapenems parallel significant increases in resistance of <span class="elsevierStyleItalic">P. aeruginosa</span> isolates to piperacillin-tazobactam, imipenem, meropenem, ceftazidime and cefepime.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Potential causes of this lack of association, as the authors correctly point out in their discussion, are that some bacterial reservoirs remain unaffected by reductions in antibiotic administration in the intensive care unit. A high percentage of patients being admitted to a given unit who have been or are currently on broad-spectrum antibiotics and carry or are infected with resistant bacteria may influence the efficacy of the combat against antimicrobial resistance of that unit, more so, if these are not detected at admission and barrier precautions are not implemented immediately. Secondly, the control of inanimate reservoirs of resistant bacteria is a formidable challenge in some units located in old buildings with contaminated tap water, sinks, and taps.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Other factors worth mentioning, that may contribute to a lack of association of antibiotic consumption and resistance rates, but are difficult to evaluate in retrospective analyses, are prescription behaviour of non-antipseudomonal antibiotics, both for therapy and prophylaxis, as well as for infections other than those captured in ENVIN-HELICS. Tracheobronchitis, for example, is currently a frequent and important indication for antibiotic administration in intubated patients,<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">8</span></a> with 61% caused by multidrug resistant bacteria and <span class="elsevierStyleItalic">P. aeruginosa</span> being the most frequent cause.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The ratio of resistant to susceptible <span class="elsevierStyleItalic">Pseudomonas</span> strains may have shifted from the years 2006 to 2016 in Spanish ICUs by reductions of susceptible strains in the denominator. This effect, admittedly, remains to be confirmed, and would require assessment of the protective or risk-increasing effects of the individual components of the Spanish National infection prevention and resistance bundles,<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">2,9–11</span></a> which were implemented in early 2009, as well as the synergistic combination of individual measures when applied in bundles. Of note is, that the above mentioned recommendations include direct antimicrobial interventions like the use of chlorhexidine for skin infection,<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">2,9</span></a> administration of topical antibiotics for selective decontamination of the digestive tract intubated patients<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">10</span></a> and a short course of intravenous antibiotics for the prevention of primary endogenous pneumonia. In fact, Álvarez-Lerma et al. show that <span class="elsevierStyleItalic">Pseudomonas</span> isolates slightly decrease from 217 to 199 over the study period, while the patient sample increases from 12,000 to 24,000 over the study period. In other words, prevention bundles may have reduced ICU-acquired infection rates, with a greater impact on infections caused by the more susceptible flora.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Finally, antibiotic diversity or heterogeneity has been associated with reductions in bacterial resistance, meaning that overuse of certain classes of drugs with the same mechanism of action, the opposite circumstance to diversity, should be avoided. Ideally, a similar percentage of exposure to the different antibiotic classes, i.e. 20% of patients, if 5 different groups are used, should be receiving beta-lactams, quinolones, tetracyclines, beta-lactam with beta-lactam inhibitor (BL-BLI), including the novel BL-BLI, and fosfomycin, in a given ICU. This concept is antagonistic to antibiotic cycling,<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">12</span></a> has been shown to be associated with lower resistance rates when compared to cycling<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">13</span></a> and has been proposed to reverse resistance in <span class="elsevierStyleItalic">P. aeruginosa</span> in a situation of homogeneity due to overuse of carbapenems.<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">6,14</span></a> Table 2 in Álvarez-Lerma et al.’s manuscript, in fact, shows marked homogeneity or lack of diversity, with noticeable preponderance of beta-lactam antibiotic use, ranging from 53 to 83% treatment days over the 10-year study period, with carbapenems being the choice in 1 of 3 patients. Achieving diversity is challenging, because randomized clinical trials-based decision algorithms are needed to support each antibiotic drug choice, but requires future studies to avoid the current overuse of carbapenems, i.e. as a carbapenem-sparing strategy.</p><p id="par0030" class="elsevierStylePara elsevierViewall">In summary, Álvarez-Lerma's study results strongly suggest that other infection control and antibiotic policy factors influence resistances rates and should be considered when generating strategic plans to combat bacterial resistance. Rather than providing a waiver for the continued effort of reducing antibiotic exposure, they should be interpreted as an indication of the need to expand our efforts and incorporate additional measures to increase efficacy in tackling the problem of bacterial resistance.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:14 [ 0 => array:3 [ "identificador" => "bib0075" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "AEMPS-Ministerio-de-Sanidad-Seguridad-Social-e-Igualdad. Plan Nacional Resistencia Antibióticos 2014. Available from: <a target="_blank" href="http://www.resistenciaantibioticos.es/es/system/files/field/files/pran_2019-2021_0.pdf?file=1%26type=node%26id=497%26force=0">http://www.resistenciaantibioticos.es/es/system/files/field/files/pran_2019-2021_0.pdf?file=1&type=node&id=497&force=0</a>." ] ] ] 1 => array:3 [ "identificador" => "bib0080" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combatting resistance in intensive care: the multimodal approach of the Spanish ICU “Zero Resistance” program" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Garnacho Montero" 1 => "F. Álvarez Lerma" 2 => "P. Ramírez Galleymore" 3 => "M. Palomar Martinez" 4 => "L. Álvarez Rocha" 5 => "F. Barcenilla Gaite" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s13054-015-0800-5" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2015" "volumen" => "19" "paginaInicial" => "114" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25880421" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0085" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antimicrobial stewardship across 47 South African hospitals: an implementation study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.J. Brink" 1 => "A.P. Messina" 2 => "C. Feldman" 3 => "G.A. Richards" 4 => "P.J. Becker" 5 => "D.A. Goff" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1473-3099(16)30012-3" "Revista" => array:7 [ "tituloSerie" => "Lancet Infect Dis" "fecha" => "2016" "volumen" => "16" "paginaInicial" => "1017" "paginaFinal" => "1025" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27312577" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1878875015012061" "estado" => "S300" "issn" => "18788750" ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0090" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.J. Price" 1 => "J.D. Sleigh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0140-6736(89)91814-x" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1970" "volumen" => "2" "paginaInicial" => "1213" "paginaFinal" => "1215" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2572917" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0095" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Changes of resistance rates in Pseudomonas aeruginosa strains are unrelated to antimicrobial consumption in ICU populations with invasive device-related infection" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Alvarez-Lerma" 1 => "P. Olaechea-Astigarraga" 2 => "R. Gimeno" 3 => "M. Catalan" 4 => "X. Nuvials" 5 => "M.P. Gracia-Arnilla" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Med Intensiva" "fecha" => "2019" "itemHostRev" => array:3 [ "pii" => "S0303846718303482" "estado" => "S300" "issn" => "03038467" ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0100" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of antibiotic use on carbapenem resistance in <span class="elsevierStyleItalic">Pseudomonas aeruginosa</span>: is there a role for antibiotic diversity?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Pluss-Suard" 1 => "A. Pannatier" 2 => "A. Kronenberg" 3 => "K. Muhlemann" 4 => "G. Zanetti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/AAC.01348-12" "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother" "fecha" => "2013" "volumen" => "57" "paginaInicial" => "1709" "paginaFinal" => "1713" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23357763" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0105" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "GdTdEI. Estudio Nacional de Vigilancia de Infección Nosocomial en UCI (ENVIN-UCI) [Internet]. Available from: <a target="_blank" href="http://hws.vhebron.net/envin-helics/">http://hws.vhebron.net/envin-helics/</a>." ] ] ] 7 => array:3 [ "identificador" => "bib0110" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Martin-Loeches" 1 => "P. Povoa" 2 => "A. Rodriguez" 3 => "D. Curcio" 4 => "D. Suarez" 5 => "J.P. Mira" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2213-2600(15)00326-4" "Revista" => array:6 [ "tituloSerie" => "Lancet Respir Med" "fecha" => "2015" "volumen" => "3" "paginaInicial" => "859" "paginaFinal" => "868" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26472037" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0115" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of a national multimodal intervention to prevent catheter-related bloodstream infection in the ICU: the Spanish experience" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Palomar" 1 => "F. Alvarez-Lerma" 2 => "A. Riera" 3 => "M.T. Diaz" 4 => "F. Torres" 5 => "Y. Agra" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Crit Care Med" "fecha" => "2013" "volumen" => "41" "paginaInicial" => "2364" "paginaFinal" => "2372" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0120" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guidelines for the prevention of ventilator-associated pneumonia and their implementation The Spanish “Zero-VAP” bundle" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.F. Alvarez" 1 => "G.M. Sanchez" 2 => "L. Lorente" 3 => "F. Gordo" 4 => "J.M. Anon" 5 => "J. Alvarez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.medin.2013.12.007" "Revista" => array:6 [ "tituloSerie" => "Med Intensiva" "fecha" => "2014" "volumen" => "38" "paginaInicial" => "226" "paginaFinal" => "236" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24594437" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0125" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevention of ventilator-associated pneumonia: the multimodal approach of the Spanish ICU “pneumonia zero” program" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Alvarez-Lerma" 1 => "M. Palomar-Martinez" 2 => "M. Sanchez-Garcia" 3 => "M. Martinez-Alonso" 4 => "J. Alvarez-Rodriguez" 5 => "L. Lorente" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/CCM.0000000000002736" "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "2018" "volumen" => "46" "paginaInicial" => "181" "paginaFinal" => "188" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29023261" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0130" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The impact of an antibiotic cycling program on empirical therapy for gram-negative infections" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "L.R. Merz" 1 => "D.K. Warren" 2 => "M.H. Kollef" 3 => "S.K. Fridkin" 4 => "V.J. Fraser" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.130.6.1672" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2006" "volumen" => "130" "paginaInicial" => "1672" "paginaFinal" => "1678" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17166981" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0135" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of diversity of antibiotic use on the development of antimicrobial resistance" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Sandiumenge" 1 => "E. Diaz" 2 => "A. Rodriguez" 3 => "L. Vidaur" 4 => "L. Canadell" 5 => "M. Olona" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/jac/dkl097" "Revista" => array:6 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2006" "volumen" => "57" "paginaInicial" => "1197" "paginaFinal" => "1204" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16565158" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0140" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Takesue" 1 => "K. Nakajima" 2 => "K. Ichiki" 3 => "M. Ishihara" 4 => "Y. Wada" 5 => "Y. Takahashi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhin.2009.11.022" "Revista" => array:6 [ "tituloSerie" => "J Hosp Infect" "fecha" => "2010" "volumen" => "75" "paginaInicial" => "28" "paginaFinal" => "32" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20346536" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735727/0000004400000007/v1_202010040640/S2173572720301594/v1_202010040640/en/main.assets" "Apartado" => array:4 [ "identificador" => "406" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735727/0000004400000007/v1_202010040640/S2173572720301594/v1_202010040640/en/main.pdf?idApp=WMIE&text.app=https://medintensiva.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572720301594?idApp=WMIE" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 27 | 33 | 60 |
2024 September | 43 | 25 | 68 |
2024 August | 50 | 31 | 81 |
2024 July | 33 | 26 | 59 |
2024 June | 42 | 50 | 92 |
2024 May | 38 | 25 | 63 |
2024 April | 32 | 29 | 61 |
2024 March | 24 | 26 | 50 |
2024 February | 27 | 37 | 64 |
2024 January | 27 | 31 | 58 |
2023 December | 31 | 33 | 64 |
2023 November | 30 | 33 | 63 |
2023 October | 23 | 28 | 51 |
2023 September | 25 | 43 | 68 |
2023 August | 17 | 18 | 35 |
2023 July | 28 | 25 | 53 |
2023 June | 24 | 17 | 41 |
2023 May | 29 | 35 | 64 |
2023 April | 20 | 17 | 37 |
2023 March | 34 | 27 | 61 |
2023 February | 30 | 26 | 56 |
2023 January | 28 | 16 | 44 |
2022 December | 44 | 45 | 89 |
2022 November | 40 | 29 | 69 |
2022 October | 47 | 38 | 85 |
2022 September | 47 | 28 | 75 |
2022 August | 35 | 43 | 78 |
2022 July | 24 | 38 | 62 |
2022 June | 28 | 26 | 54 |
2022 May | 31 | 29 | 60 |
2022 April | 30 | 46 | 76 |
2022 March | 36 | 59 | 95 |
2022 February | 22 | 34 | 56 |
2022 January | 38 | 33 | 71 |
2021 December | 36 | 37 | 73 |
2021 November | 46 | 25 | 71 |
2021 October | 76 | 67 | 143 |
2021 September | 48 | 44 | 92 |
2021 August | 41 | 44 | 85 |
2021 July | 41 | 25 | 66 |
2021 June | 26 | 26 | 52 |
2021 May | 32 | 38 | 70 |
2021 April | 95 | 79 | 174 |
2021 March | 77 | 34 | 111 |
2021 February | 55 | 30 | 85 |
2021 January | 27 | 33 | 60 |